Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models

Variants of TREM2 are associated with Alzheimer's disease (AD). To study whether increasing TREM2 gene dosage could modify the disease pathogenesis, we developed BAC transgenic mice expressing human TREM2 (BAC-TREM2) in microglia. We found that elevated TREM2 expression reduced amyloid burden i...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Neuron (Cambridge, Mass.) Ročník 97; číslo 5; s. 1032
Hlavní autoři:	Lee, C Y Daniel, Daggett, Anthony, Gu, Xiaofeng, Jiang, Lu-Lin, Langfelder, Peter, Li, Xiaoguang, Wang, Nan, Zhao, Yingjun, Park, Chang Sin, Cooper, Yonatan, Ferando, Isabella, Mody, Istvan, Coppola, Giovanni, Xu, Huaxi, Yang, X William
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 07.03.2018
Témata:	Alzheimer Disease - genetics Alzheimer Disease - pathology Animals Animals, Newborn Cells, Cultured Cellular Reprogramming Techniques - methods Disease Models, Animal Female Gene Dosage - genetics Humans Male Membrane Glycoproteins - biosynthesis Membrane Glycoproteins - genetics Memory - physiology Mice Mice, Inbred C57BL Mice, Transgenic Microglia - pathology Microglia - physiology Organ Culture Techniques Phenotype Receptors, Immunologic - biosynthesis Receptors, Immunologic - genetics RNA-sequencing reprogramming mouse Alzheimer’s disease BAC neuroinflammation TREM2 amyloid plaque gene dosage microglia
ISSN:	1097-4199, 1097-4199
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!